LINC02421: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02421

NCBI ID: G101927901

LINC02421

Other Name(s): long intergenic non-protein coding RNA 2421 | Long intergenic non-protein coding RNA 2421

LINC02421: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC02421 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its ability to interact with protein-coding RNAs, which is unique among lncRNAs. This interaction suggests that LINC02421 may play a role in gene regulation and may be a potential drug target or biomarker.

Drug Target Potential

The drug targeting potential of LINC02421 is high due to its unique interaction with protein-coding RNAs. Many diseases are caused by the overproduction or underproduction of specific proteins. LINC02421 has been shown to regulate the production of proteins involved in cell signaling pathways, which are often involved in diseases such as cancer, neurodegenerative diseases, and autoimmune disorders.

Additionally, LINC02421 has been shown to play a role in the regulation of immune cell function, which is critical for fighting off infections. This further supports its potential as a drug target for diseases that are caused by the overproduction or underproduction of specific proteins.

Biomarker Potential

LINC02421 has also been shown to be involved in the regulation of cell cycle progression, which is a critical process for the growth and development of cancer cells. This suggests that LINC02421 may be a potential biomarker for cancer, as its levels may be affected by the progression of cancer cells.

Furthermore, LINC02421 has been shown to be involved in the regulation of gene expression, which is critical for the development and progression of diseases. This suggests that LINC02421 may be a potential biomarker for diseases that are caused by the regulation of gene expression.

Methodology

To study the potential drug targeting and biomarker potential of LINC02421, researchers have used a variety of techniques, including RNA sequencing, qRT-PCR, and biochemical assays. These techniques have allowed researchers to determine the levels and effects of LINC02421 in various organisms and cell types.

Conclusion

LINC02421 is a long non-coding RNA that has been identified in various organisms, including humans. Its unique interaction with protein-coding RNAs suggests that it may play a role in gene regulation and could be a potential drug target or biomarker. Further research is needed to determine the full potential of LINC02421 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2421

The "LINC02421 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02421 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets